All In Biotech

Drug Trial Radar · NCT01929629

A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD0914

A Phase I, Randomized, Placebo-controlled, Single-center Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD0914 After a Single Oral Administration and to Assess the Effect of Food in Healthy Adult Volunteers

Last checked: Nov 20, 2026Latest source record: Apr 15, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 100 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

100

Actual

Start

Sep 2013

Primary completion

Mar 2014

Study completion Mar 2014

Sponsor

Lead sponsor
AstraZenecaAstraZeneca (AZN)
Sponsor type
Industry
First posted
Aug 28, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Basic science
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the safety and tolerability of orally administered AZD0914 in healthy adult subjects.

Conditions

  • Gonococcal (GC) Infection

Interventions

  • Part ADrug

    Single ascending doses

  • Part BDrug

    Single doses food effect. Subjects to receive 2 single doses, one in fed and one in fasted.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Description of the safety profile in terms of adverse events; blood pressure, heart rate and body temperature; electrocardiograms; telemetry; clinical chemistry ; haematology and physical examinationTime frame: From admission on day -1 until follow up. ( Max 16 days)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Research Site

    Overland Park, Kansas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.